ADVFN US – Market Content Editor
-

Invivyd Reports Positive Phase 3 LIBERTY Results for VYD2311 and Plans Accelerated Approval Submission
Invivyd reported statistically significant Phase 3 safety and tolerability results for VYD2311 compared with an mRNA-based COVID-19 vaccine and said it plans to pursue an Accelerated Approval BLA pending supportive results from its ongoing DECLARATION study. Key Investor Takeaways Why IVVD Stock Is in Focus Invivyd’s Phase 3 LIBERTY study produced statistically significant results on…
-

Kraig Labs Ships First Commercial Spider Silk Order for Performance Textile Development
Kraig Biocraft Laboratories has shipped its first commercial recombinant spider silk yarn order to a globally recognized performance sports brand, moving its material into a customer product-development program for the first time. Key Investor Takeaways Why KBLB Stock Is in Focus Kraig Labs has reached a key commercialization milestone by shipping its first commercial order…
-

American Fusion Outlines Texatron Plasma Compression and Confinement Approach for Fusion Testing
American Fusion has detailed the theoretical physics behind its Texatron Fusion Engine, outlining how pulsed magnetic compression and a rifled chamber could potentially create and confine plasma while identifying the key performance requirements that still need experimental validation. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion has provided a more detailed technical…
-

Netlist Files New ITC Patent Action Against Micron Over HBM Technology for AI Computing
Netlist has filed a new U.S. International Trade Commission complaint seeking exclusion and cease and desist orders against Micron Technology and downstream customers Nvidia, Broadcom and Google over alleged infringement of two High Bandwidth Memory patents. Key Investor Takeaways Why NLST Stock Is in Focus Netlist has initiated another patent enforcement action against Micron, this…
-

Lightwave Logic Appoints Edward H. Kennedy to Board as Commercial Strategy Advances
Lightwave Logic has appointed telecom and networking executive Edward H. Kennedy to its Board of Directors, adding experience in corporate transformations, M&A and strategic alternatives as the company advances commercialization of its electro-optic polymer platform. Key Investor Takeaways Why LWLG Stock Is in Focus Lightwave Logic has expanded its board with the appointment of Edward…
-

ProText Mobility ABSA Digital-Asset Custody Pilot Advances RWA and Uplist Strategy
ProText Mobility says its chairman has been confirmed as the first pilot client in ABSA’s digital-asset custody onboarding process, adding an institutional custody component to the company’s broader real-world asset and regulated-exchange uplist strategy. Key Investor Takeaways Why TXTM Stock Is in Focus The central development in ProText Mobility’s shareholder update is the confirmation that…
-

Getchell Gold Secures $300,000 Strategic Investment for Fondaway Canyon Exploration
Getchell Gold is raising $300,000 from Buzbuzian Capital through a unit offering, providing additional funding for exploration at its flagship Fondaway Canyon gold project in Nevada. Key Investor Takeaways Why GGLDF Stock Is in Focus Getchell Gold announced that Buzbuzian Capital will invest $300,000 to acquire 1 million units of the company. The transaction implies…
-

Plug Power Signs 280 MW Electrolyzer Supply Agreement as Arcadia Partnership Targets More Than 1 GW of e-SAF Projects
Plug Power will supply electrolyzers for Arcadia eFuels’ flagship Project ENDOR in Denmark, while a broader cooperation agreement positions the company as preferred supplier for four additional projects in Europe and the Americas. Key Investor Takeaways Why PLUG Stock Is in Focus Plug Power has secured a 280 MW electrolyzer supply agreement with Arcadia eFuels…
-

Volt Carbon Q3 2026 Results Highlight US$4.1 Million in Purchase Orders as Commercialization Advances
Volt Carbon reported minimal third-quarter revenue and a C$805,930 net loss, while approximately US$4.1 million in purchase orders shifted investor attention toward execution of its vermiculite processing and advanced materials programs. Key Investor Takeaways Why TORVF Stock Is in Focus Volt Carbon’s Q3 2026 results show a substantial gap between current reported revenue and contracted…
-

Immix Biopharma Reports 89% Complete Response Rate in Phase 2 NXC-201 Trial
Immix Biopharma, Inc. (NASDAQ:IMMX) reported interim data from its NEXICART-2 Phase 2 clinical trial of NXC-201 in patients with relapsed or refractory AL amyloidosis. According to the company, NXC-201 produced an 89% complete response rate across all 45 enrolled patients, based on an assessment by an independent review committee. NXC-201 is an investigational CAR-T therapy…